High Note Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
High Note Wealth's BMY Position: Q2 2026 in Review
High Note Wealth reduced its Bristol-Myers Squibb (BMY) stake by 3.4% in Q2 2026, selling an estimated $3.16K and leaving 1,586 shares worth $91.4K. The position accounts for 0.02% of the portfolio, ranked #164.
High Note Wealth first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $99.5K in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- High Note Wealth held 1,586 shares of Bristol-Myers Squibb worth $91.4K as of Q2 2026.
- High Note Wealth sold 55 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.16K.
- Bristol-Myers Squibb made up 0.02% of High Note Wealth's portfolio in Q2 2026, its #164 holding.
- High Note Wealth first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
- High Note Wealth's Bristol-Myers Squibb position peaked at $99.5K in Q1 2026.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on High Note Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.